Nicorandil, its denitrated metabolite, SG-86 and naturally occurring vasodilators synergistically interact on adenosine-induced vasodepression in rats: Special reference to adrenomedullin

Fundamental and Clinical Pharmacology

Volumn 13, Issue 1, 1999, Pages 27-33

  Sakai, Kazushige ^a   Saito, Keiji ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Endogenous vasodilators; Enhancement of adenosine effects; Glibenclamide sensifive K+ channels; Nicorandil and its metabolite (SG 86)

Indexed keywords

ADENOSINE; ADRENOMEDULLIN; N (2 HYDROXYETHYL)NICOTINAMIDE; NICORANDIL; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0033304219     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1999.tb00317.x     Document Type: Article

References (34)

1. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs
2. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation
3. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels
4. Antihypertensive and haemodynamic properties of the potassium channel activating (-)-enantiomer of cromakalim in animal models
5. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels
6. Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin
7. Pharmacokinetic profile of nicorandil in humans: An overview
8. 2 receptor-mediated vasodepression does not involve a pertussis toxin-sensitive G protein
9. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats
10. The cardioprotective effects of nicorandil
11. Cromakalim, nicorandil and pinacidil: Novel drugs which open potassium channels in smooth muscle
12. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma
13. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP
14. Pharmacology and therapeutic effects of nicorandil
15. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
16. Clinical profile of nicorandil: An overview of its haemodynamic properties and therapeutic efficacy
17. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles
18. The autonomic and somatic motor nervous systems
19. Role of adenosine in the heart and circulation
20. Calcitonin gene-related peptide in cardiovascular tissues of the rat
21. The role of potassium channels in the regulation of peripheral resistance
22. Clinical studies for the sites of production and clearance of circulating adrenomedullin in human subjects
23. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function
24. Adrenomedullin mediates coronary vasodilation through adenosine receptors and K(ATP) channels
25. Antiischemic effects of nicorandil during coronary angioplasty in humans
26. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: Comparison with cromakalim
27. Nicorandil: Animal pharmacology
28. Differential effects of nicorandil on the vasodepressor responses to vasoactive polypeptides administered intravenously to rats
29. Pharmacodynamic and metabolism studies on a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75)
30. Comparison of the potentiating effects of nicorandil and its denitrated metabolite (SG-86) on the adenosine-induced vasodepression in rats
31. Reciprocal interactions among neuropeptides and adenosine in the cardiovascular system of rats: A role of K(ATP) channels
32. Synergism between low-dose nicorandil and neuropeptides on adenosine-induced vasodepression in rats
33. Synergistic effect of calcitonin gene-related peptide on adenosine-induced vasodepression in rats
34. Nicorandil as a hybrid between nitrates and potassium channel activators